185 related articles for article (PubMed ID: 15878105)
1. Testicular dose and hormonal changes after radiotherapy of rectal cancer.
Hermann RM; Henkel K; Christiansen H; Vorwerk H; Hille A; Hess CF; Schmidberger H
Radiother Oncol; 2005 Apr; 75(1):83-8. PubMed ID: 15878105
[TBL] [Abstract][Full Text] [Related]
2. Risk of hypogonadism from scatter radiation during pelvic radiation in male patients with rectal cancer.
Yau I; Vuong T; Garant A; Ducruet T; Doran P; Faria S; Liberman S; Richard C; Letellier F; Charlebois P; Loungnarath R; Stein B; Devic S
Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1481-6. PubMed ID: 19147304
[TBL] [Abstract][Full Text] [Related]
3. Radiotherapy for rectal cancer is associated with reduced serum testosterone and increased FSH and LH.
Bruheim K; Svartberg J; Carlsen E; Dueland S; Haug E; Skovlund E; Tveit KM; Guren MG
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):722-7. PubMed ID: 18262088
[TBL] [Abstract][Full Text] [Related]
4. Alterations in hormone levels after adjuvant chemoradiation in male rectal cancer patients.
Yoon FH; Perera F; Fisher B; Stitt L
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1186-90. PubMed ID: 19095371
[TBL] [Abstract][Full Text] [Related]
5. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
6. Hormonal predictors of prostate cancer.
Sofikerim M; Eskicorapci S; Oruç O; Ozen H
Urol Int; 2007; 79(1):13-8. PubMed ID: 17627161
[TBL] [Abstract][Full Text] [Related]
7. [Preliminary results of reproductive system function assessment in young men after Hodgkin's disease therapy].
Moryl-Bujakowska A; Balwierz W; Małek A; Sztefko K
Przegl Lek; 2010; 67(6):382-6. PubMed ID: 21344766
[TBL] [Abstract][Full Text] [Related]
8. Testosterone production is better preserved after 16 than 20 Gray irradiation treatment against testicular carcinoma in situ cells.
Bang AK; Petersen JH; Petersen PM; Andersson AM; Daugaard G; Jørgensen N
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):672-6. PubMed ID: 19250763
[TBL] [Abstract][Full Text] [Related]
9. Radiation dose to testes and risk of infertility from radiotherapy for rectal cancer.
Mazonakis M; Damilakis J; Varveris H; Gourtsouiannis N
Oncol Rep; 2006 Mar; 15(3):729-33. PubMed ID: 16465437
[TBL] [Abstract][Full Text] [Related]
10. [Hormonal evaluation in infertile men].
Bourcigaux N; Christin-Maître S
Gynecol Obstet Fertil; 2008 May; 36(5):551-6. PubMed ID: 18462981
[TBL] [Abstract][Full Text] [Related]
11. Time course of serum testosterone and luteinizing hormone levels after cessation of long-term luteinizing hormone-releasing hormone agonist treatment in patients with prostate cancer.
Kaku H; Saika T; Tsushima T; Ebara S; Senoh T; Yamato T; Nasu Y; Kumon H
Prostate; 2006 Mar; 66(4):439-44. PubMed ID: 16329145
[TBL] [Abstract][Full Text] [Related]
12. Alleviation of pre-exposure of mouse brain with low-dose 12C6+ ion or 60Co gamma-ray on male reproductive endocrine damages induced by subsequent high-dose irradiation.
Zhang H; Liu B; Zhou Q; Zhou G; Yuan Z; Li W; Duan X; Min F; Xie Y; Li X
Int J Androl; 2006 Dec; 29(6):592-6. PubMed ID: 17121657
[TBL] [Abstract][Full Text] [Related]
13. Testicular dose in prostate cancer radiotherapy: impact on impairment of fertility and hormonal function.
Boehmer D; Badakhshi H; Kuschke W; Bohsung J; Budach V
Strahlenther Onkol; 2005 Mar; 181(3):179-84. PubMed ID: 15756522
[TBL] [Abstract][Full Text] [Related]
14. Serum hormones in patients with nonobstructive azoospermia after microdissection testicular sperm extraction.
Ishikawa T; Yamaguchi K; Chiba K; Takenaka A; Fujisawa M
J Urol; 2009 Oct; 182(4):1495-9. PubMed ID: 19683738
[TBL] [Abstract][Full Text] [Related]
15. Radiation therapy induced changes in male sex hormone levels in rectal cancer patients.
Dueland S; Guren MG; Olsen DR; Poulsen JP; Magne Tveit K
Radiother Oncol; 2003 Sep; 68(3):249-53. PubMed ID: 13129632
[TBL] [Abstract][Full Text] [Related]
16. Individual variation of hormonal recovery after cessation of luteinizing hormone-releasing hormone agonist therapy in men receiving long-term medical castration therapy for prostate cancer.
Kobayashi T; Nishizawa K; Mitsumori K
Scand J Urol Nephrol; 2006; 40(3):198-203. PubMed ID: 16809259
[TBL] [Abstract][Full Text] [Related]
17. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of endocrine profile, hypothalamic-pituitary-testis axis and semen quality in multiple sclerosis.
Safarinejad MR
J Neuroendocrinol; 2008 Dec; 20(12):1368-75. PubMed ID: 19094084
[TBL] [Abstract][Full Text] [Related]
19. Phase II dose escalation study of image-guided adaptive radiotherapy for prostate cancer: use of dose-volume constraints to achieve rectal isotoxicity.
Vargas C; Yan D; Kestin LL; Krauss D; Lockman DM; Brabbins DS; Martinez AA
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):141-9. PubMed ID: 16111582
[TBL] [Abstract][Full Text] [Related]
20. [Effects of fenvalerate on reproductive and endocrine systems of male rats].
Hu JY; Wang SL; Zhao RC; Yang J; Chen JH; Song L; Wang XR
Zhonghua Nan Ke Xue; 2002; 8(1):18-21. PubMed ID: 12479040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
